<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">10</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2017-16-4-62-68</article-id><article-categories><subj-group subj-group-type="toc-heading"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">The nutritional status and efficiency of different types of nutritional support in patients with non-Hodgkin's lymphomas (NHL) in active phase of treatment</article-title><trans-title-group xml:lang="ru"><trans-title>Нутритивный статус и эффективность различных типов нутритивной поддержки у пациентов с неходжкинскими лимфомами в активной фазе лечения</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4296-3345</contrib-id><name-alternatives><name xml:lang="en"><surname>Vashura</surname><given-names>A. Yu.</given-names></name><name xml:lang="ru"><surname>Вашура</surname><given-names>А.Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, the head of department of scientific basis of nutrition and nutritional metabolic therapy</p><p>Russia 117997, Moscow, Samory Mashela st., 1</p></bio><email>avashura@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shamsutdinova</surname><given-names>M. S.</given-names></name><name xml:lang="ru"><surname>Шамсутдинова</surname><given-names>М.С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7461-0050</contrib-id><name-alternatives><name xml:lang="en"><surname>Litvinov</surname><given-names>D. V.</given-names></name><name xml:lang="ru"><surname>Литвинов</surname><given-names>Д.В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-11-09" publication-format="electronic"><day>09</day><month>11</month><year>2017</year></pub-date><volume>16</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>62</fpage><lpage>68</lpage><history><date date-type="received" iso-8601-date="2018-08-09"><day>09</day><month>08</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/10">https://hemoncim.com/jour/article/view/10</self-uri><abstract xml:lang="en"><p>The development of the tumor process and chemotherapy with its after-effects, can cause nutritional disorders that aggravate the course of the disease and complicate recovery of patient. It is very important to choose the right type of nutritional support (parenteral or enteral nutrition). The aim of the study was to determine changes in the nutritional status of children with non-Hodgkin's lymphomas (NHL), its effect on the duration of aplasia and development severe complications in the active treatment process and to assess the impact of different types of nutritional support on these parameters. The retrospective study with a comparative analysis was performed. It included 54 patients, including 40 (74%) boys, aged 1–17 years (median – 9 years). We analyzed anthropometric parameters – body mass index (BMI), triceps skinfold thickness (TSF), mid-upper arm muscle circumference (MUAMC) – on five periods of time respective to the course of therapy: "0" – 1–3 days before the beginning of cytoreductive phase of treatment; "1, 2, 3, 4" – the last day of the therapy and 4 days after it. The reliable positive dynamics of TSF during monitoring period was found (p &lt; 0.05), it was more pronounced in patients with initial nutritional insufficiency (p &lt; 0.05). It was associated with a greater incidence of severe complications (p = 0.02). Comparative analysis of types of nutritional support showed that the most effective is combination of enteral and parenteral nutrition, although the latest is associated with a greater frequency of nephro- and hepatotoxicity.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>children</kwd><kwd>oncology</kwd><kwd>hematology</kwd><kwd>non-Hodgkin's lymphoma</kwd><kwd>nutritional status</kwd><kwd>nutritional support</kwd><kwd>nutrition</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>дети</kwd><kwd>онкогематология</kwd><kwd>неходжкинская лимфома</kwd><kwd>нутритивный статус</kwd><kwd>нутритивная поддержка</kwd><kwd>питание</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Снеговой А.В., Салтанов А.И., Манзюк Л.В. и др. Нутритивная недостаточность у онкологических больных: принципы коррекции. РМЖ. Онкология, 2013, №1: 14-21.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Bauer J., Jürgens H., Frühwald M.C. Important Aspects of Nutrition in Children with Cancer Adv Nutr 2011; 2: 67-77.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Fearon K.C., Voss A.C., Hustead D.S. Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis Am J Clin Nutr 2006; 83: 1345-50.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Arends J., Bodoky G., Bozzetti F., Fearon K., Muscaritoli M., Selga G., van Bokhorst M.A.E., von Meyenfeldt M. ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clinical Nutrition 2006; 25: 245-59.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Viana M.B., Murao M., Ramos G., et al. Malnutrition as a prognostic factor in lymphoblastic leukaemia: a multivariate analysis. Arch Dis Child 1994; 71: 304-10.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Lobato-Mendizabal E., Ruiz-Arguelles G.J.,Marin-Lopez A. Leukemia and nutrition. I: Malnutrition is an adverse prognostic factor in the outcome of treatment of patients with standart-risk acute lymphoblastic leukaemia. Leuk Res 1989; 13: 899-906.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Rickard K.A., Detamore C.M., Coates T.D., et al. Effect of nutrition staging on treatment delays and outcome in stage four neuroblastoma. Cancer 1983; 52: 587-98.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Васильева Е.С., Вашура А.Ю., Литвинов Д.В. Нутритивный статус у детей с онкологическими и гематологическими заболеваниями, находящихся на лечении в ФГБУ «ФНКЦ ДГОИ им. Дмитрия Рогачева» (результаты скринингового исследования). «Современная онкология», 2016, т. 18 (4): 48-52.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Руководство по парентеральному и энтеральному питанию (Под ред. И.Е. Хорошилова). - СПб.: Нормед-Издат, 2001, 376.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Goere D., Cunha A. Sa. Parenteral and enteral nutritional support. Villejuif, France: Journal of Visceral Surgery 2015; 8-13.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Bozzetti F. Нутриционнаяподдержкавонкологии. В кн.: Основы клинического питания. Материалы лекций для курсов Европейской ассоциации парентерального питания. - Петрозаводск: ИнтелТек, 2004.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Костюченко А.Л., Железный О.К., Шведов А.Г. Энтеральное искусственное питание в клинической медицине. - Петрозаводск: ИнтелТек, 2001.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Снеговой А.В., Сельчук В.Ю., Манзюк Л.В., Салтанов А.И., Снигур П.В. К вопросу об энтеральном питании в онкологии. РМЖ, 2007; 25: 19-24.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Mehta N.M., Corkins M.R., Lyman B., Malone A., Goday P.S., Carney L., Monczka J., Plogsted S.W., Schwenk W.F. Defining pediatric malnutrition: a paradigm shift toward etiology-related definitions. JPEN 2013; 1-22.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Вашура А.Ю., Коновалова М.В., Скоробогатова Е.В., Бельмер С.В, Цейтлин Г.Я. Нутритивный статус и тканевый состав тела у детей после трансплантации гемопоэтических стволовых клеток. Онкогематология, 2011, №4, 33-38.</mixed-citation></ref></ref-list></back></article>
